297 related articles for article (PubMed ID: 15447697)
1. A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.
Maizels M; Blumenfeld A; Burchette R
Headache; 2004 Oct; 44(9):885-90. PubMed ID: 15447697
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis--a double-blind, multicentre, randomized placebo-controlled dose-response study.
Pfaffenrath V; Diener HC; Fischer M; Friede M; Henneicke-von Zepelin HH;
Cephalalgia; 2002 Sep; 22(7):523-32. PubMed ID: 12230594
[TBL] [Abstract][Full Text] [Related]
3. A double-blind placebo-controlled pilot study of sublingual feverfew and ginger (LipiGesicâ„¢ M) in the treatment of migraine.
Cady RK; Goldstein J; Nett R; Mitchell R; Beach ME; Browning R
Headache; 2011; 51(7):1078-86. PubMed ID: 21631494
[TBL] [Abstract][Full Text] [Related]
4. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study.
Guilbot A; Bangratz M; Ait Abdellah S; Lucas C
BMC Complement Altern Med; 2017 Aug; 17(1):433. PubMed ID: 28854909
[TBL] [Abstract][Full Text] [Related]
5. Feverfew for migraine prophylaxis.
Henneicke-von Zepelin HH
Headache; 2006 Mar; 46(3):531. PubMed ID: 16618282
[No Abstract] [Full Text] [Related]
6. Evidenced-based use of botanicals, minerals, and vitamins in the prophylactic treatment of migraines.
Rios J; Passe MM
J Am Acad Nurse Pract; 2004 Jun; 16(6):251-6. PubMed ID: 15264611
[TBL] [Abstract][Full Text] [Related]
7. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial.
MacLennan SC; Wade FM; Forrest KM; Ratanayake PD; Fagan E; Antony J
J Child Neurol; 2008 Nov; 23(11):1300-4. PubMed ID: 18984840
[TBL] [Abstract][Full Text] [Related]
8. Feverfew for preventing migraine.
Pittler MH; Ernst E
Cochrane Database Syst Rev; 2004; (1):CD002286. PubMed ID: 14973986
[TBL] [Abstract][Full Text] [Related]
9. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
Gaul C; Diener HC; Danesch U;
J Headache Pain; 2015; 16():516. PubMed ID: 25916335
[TBL] [Abstract][Full Text] [Related]
10. Feverfew for preventing migraine.
Pittler MH; Vogler BK; Ernst E
Cochrane Database Syst Rev; 2000; (3):CD002286. PubMed ID: 10908545
[TBL] [Abstract][Full Text] [Related]
11. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.
Murphy JJ; Heptinstall S; Mitchell JR
Lancet; 1988 Jul; 2(8604):189-92. PubMed ID: 2899663
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review.
Ernst E; Pittler MH
Public Health Nutr; 2000 Dec; 3(4A):509-14. PubMed ID: 11276299
[TBL] [Abstract][Full Text] [Related]
13. Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study.
Shrivastava R; Pechadre JC; John GW
Clin Drug Investig; 2006; 26(5):287-96. PubMed ID: 17163262
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of feverfew as prophylactic treatment of migraine.
Johnson ES; Kadam NP; Hylands DM; Hylands PJ
Br Med J (Clin Res Ed); 1985 Aug; 291(6495):569-73. PubMed ID: 3929876
[TBL] [Abstract][Full Text] [Related]
15. Non-pharmacological approach to migraine prophylaxis: part II.
Schiapparelli P; Allais G; Castagnoli Gabellari I; Rolando S; Terzi MG; Benedetto C
Neurol Sci; 2010 Jun; 31 Suppl 1():S137-9. PubMed ID: 20464605
[TBL] [Abstract][Full Text] [Related]
16. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
[TBL] [Abstract][Full Text] [Related]
17. New medications show promise for migraine sufferers.
Dent Today; 2002 Oct; 21(10):70. PubMed ID: 12382492
[No Abstract] [Full Text] [Related]
18. Usefulness of nutraceuticals in migraine prophylaxis.
D'Onofrio F; Raimo S; Spitaleri D; Casucci G; Bussone G
Neurol Sci; 2017 May; 38(Suppl 1):117-120. PubMed ID: 28527067
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention--a randomized, double-blind, multicentre, placebo-controlled study.
Diener HC; Pfaffenrath V; Schnitker J; Friede M; Henneicke-von Zepelin HH
Cephalalgia; 2005 Nov; 25(11):1031-41. PubMed ID: 16232154
[TBL] [Abstract][Full Text] [Related]
20. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.
Bruijn J; Duivenvoorden H; Passchier J; Locher H; Dijkstra N; Arts WF
Cephalalgia; 2010 Dec; 30(12):1426-34. PubMed ID: 20974610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]